Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000586210 | SCV000696147 | uncertain significance | not provided | 2017-02-17 | criteria provided, single submitter | clinical testing | Variant summary: The MLH1 c.2135G>C (p.Trp712Ser) variant involves the alteration of a conserved nucleotide. 3/4 in silico tools predict a damaging outcome for this variant (SNPs&GO not captured due to low reliability index). 5/5 splice prediction tools predict no significant impact on normal splicing. ESE finder predicts that this variant may create SC35 and SF2/ASF ESE sites. However, these predictions have yet to be confirmed by functional studies. This variant is absent in the large control database ExAC (0/121230 control chromosomes). Overall, there were very few data points in the literature and databases regarding this variant. Taken together, this variant is classified as VUS. |